Under way, not recruiting
Virtual Incision Robotically Assisted Surgical Device Use in Minimally Invasive Colectomy
NCT04703829 · Virtual Incision Corporation · Updated 1 Oct 2026
- What is being tested
- VI-RASD use in minimally invasive right or left colectomy; Right or Left colectomy
- For
- Colon Cancer; Colon Polyp; Diverticular Diseases; Inflammatory Bowel Diseases
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 22 years to 85 years. About 30 people. The full rules are on the registry page.
- Where
- United States (3 sites)
- When
- Starts or started 9 Aug 2021, ends Jan 2028. Registered 11 Jan 2021.
- Results
- Posted on the registry on 1 Oct 2026.
In the researchers' words
For patients with colon polyps (clumps of cells in the lining of the colon) treatment often requires removal of the affected portion of the colon. Both conventional laparoscopic and robotically assisted minimally invasive surgery have been shown to have reduced complication rates and shorter hospital stays. This study aims to look at the use of the VI RASD as a robotic surgical device in right or left colectomy procedures to see if the device performs as intended and is safe for use.
Sites
- Bryan Medical CenterLincoln, Nebraska, United States
- Lankeanu Medical CenterWynnewood, Pennsylvania, United States
- Roper Saint Francis Mount PleasantMt. Pleasant, South Carolina, United States